Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. SPY
2. USO
3. IONQ
4. QCOM
5. IONS
6. ORCL
7. AAPL
8. NVS
9. AZN
10. HOOD

Go back to Clearmind Advances MDMA-N-acylethanolamines IP for the Treatment of PTSD Amid Rising U.S. Federal Support for Psychedelic Innovation
(NASDAQ: CMND) Delayed: 1.03 --0 (-0%)
Previous Close $1.03    52 Week High $ 
Open $1.03    52 Week Low $ 
Day High $1.03    P/E N/A 
Day Low $1.03    EPS $ 
Volume 17,749